142 related articles for article (PubMed ID: 37555546)
1. Assessment of bleeding risk in low-weight patients receiving prophylactic subcutaneous unfractionated heparin.
Jatis AJ; Nei SD; Zieminski JJ; Mara K; Krauter AK
Vasc Med; 2023 Oct; 28(5):443-448. PubMed ID: 37555546
[TBL] [Abstract][Full Text] [Related]
2. Standard subcutaneous dosing of unfractionated heparin for venous thromboembolism prophylaxis in surgical ICU patients leads to subtherapeutic factor Xa inhibition.
Cheng SS; Nordenholz K; Matero D; Pearlman N; McCarter M; Gajdos C; Hamiel C; Baer A; Luzier E; Tran ZV; Olson T; Queensland K; Lutz R; Wischmeyer P
Intensive Care Med; 2012 Apr; 38(4):642-8. PubMed ID: 22231174
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis.
Bauman JA; Church E; Halpern CH; Danish SF; Zaghloul KA; Jaggi JL; Stein SC; Baltuch GH
Neurosurgery; 2009 Aug; 65(2):276-80; discussion 280. PubMed ID: 19625905
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
[TBL] [Abstract][Full Text] [Related]
5. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
[TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
7. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Otten HM; Rutjes AW
Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736
[TBL] [Abstract][Full Text] [Related]
8. Clinical Experience With Pharmacological Venous Thromboembolism Prophylaxis in the Underweight and Critically Ill.
Carter C; Bushwitz J; Gowan M; Pope H; Human T; Gibson G; Owen E; Hampton N; Whitman C
Ann Pharmacother; 2016 Oct; 50(10):832-9. PubMed ID: 27371544
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Venous Thromboembolism and Safety of Perioperative Subcutaneous Heparin During Inflatable Penile Prosthesis Surgery.
Hebert KJ; Findlay BL; Yang DY; Houlihan MD; Bole R; Avant RA; Andrews JR; Jimbo M; Ziegelmann MJ; Helo S; Köhler TS
Urology; 2021 Nov; 157():155-160. PubMed ID: 34411598
[TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
Forster R; Stewart M
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Twice Daily Versus Thrice Daily Subcutaneous Unfractionated Heparin for Venous Thromboembolism Prophylaxis at a Tertiary Medical Center.
Sorgi MW; Roach E; Bauer SR; Bass S; Militello M; Welch S; Lam S; Reddy AJ; Torbic H
J Pharm Pract; 2022 Apr; 35(2):190-196. PubMed ID: 33016183
[TBL] [Abstract][Full Text] [Related]
14. Venous Thromboembolism Prophylaxis in Low Body Weight Critically Ill Patients.
Knox H; Edwin SB; Giuliano C; Paxton RA
J Intensive Care Med; 2024 May; 39(5):493-498. PubMed ID: 38111295
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of High-Dose Unfractionated Heparin Versus High-Dose Enoxaparin for Venous Thromboembolism Prevention in Morbidly Obese Hospitalized Patients.
Mason SW; Barber A; Jones E; Chen SL; Moll S; Northam K
Am J Med; 2020 Jun; 133(6):e249-e259. PubMed ID: 31862336
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill Patient.
Reynolds PM; Van Matre ET; Wright GC; McQueen RB; Burnham EL; Ho PJM; Moss M; Vandivier RW; Kiser TH;
Pharmacotherapy; 2019 Mar; 39(3):232-241. PubMed ID: 30592541
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors for PTT prolongation in patients receiving low-dose unfractionated heparin thromboprophylaxis.
Feinbloom D; Freed JA; Carbo A; Jung Y; Adra M; Herzig SJ
J Thromb Thrombolysis; 2021 Jul; 52(1):331-337. PubMed ID: 33006065
[TBL] [Abstract][Full Text] [Related]
20. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
Marciniak CM; Kaplan J; Welty L; Chen D
PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
